Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus.
about
Regulation of adaptive immunity; the role of interleukin-10Herpesvirus exploitation of host immune inhibitory pathwaysPeriovulatory leukocyte infiltration in the rat ovarySalivary gland NK cells are phenotypically and functionally uniqueReduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice.IL-10 production by CD4+ effector T cells: a mechanism for self-regulation.IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence.IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infectionInterleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice.Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus.Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.The role of IL-10 in regulating immunity to persistent viral infectionsActivating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection.Nonredundant roles for B cell-derived IL-10 in immune counter-regulationIL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection.The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.Chronic infections with viruses or parasites: breaking bad to make good.IL-10 restricts memory T cell inflation during cytomegalovirus infection.The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.Suppression of interleukin-6 increases enterovirus A71 lethality in mice.Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection.Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies
P2860
Q21131215-9C268D66-E449-4F8D-9EBA-F53DE004EFE0Q27013680-8D941928-5C42-4644-9AF0-66DE693487A3Q28581117-755C770E-9023-4519-9F86-9759E5548B81Q33797827-CF7E3D1C-1F84-4083-BA95-2306B2639866Q33925866-E2F48E4A-E324-4D21-B6B1-C8F41EA25A5CQ33927028-34F08E94-94DE-407F-81EE-25AE94FA04F2Q34372333-D0BB5870-A99D-47FE-8125-657418E8E0D6Q34374800-44E8201E-40BC-4DEE-9CE2-92382FA69B8AQ34565123-ECBF8D89-C700-4B6D-A39D-3E868817DDDAQ35637826-7EF68896-1407-4164-85A5-3174FCC55A86Q36214992-57894A60-5F38-4BA5-A496-F269D1DE4998Q36380567-A23C34C3-ABD6-47F4-B46A-FD55733C4791Q37377451-D09218EE-4040-4D5A-96A9-F8E61B91DF5BQ37409360-FF3225FE-5877-4309-A575-E791ACB85B44Q38445112-AD5D2305-8F9B-4962-9BC8-514BDC260BE0Q38940024-9D6DC645-8F7E-4223-ACF4-C440325496D3Q39051489-87758347-9C9B-4D99-BD83-292BDFC0F219Q40746828-D97E7BE3-E375-487F-909A-1B3F738EF98BQ43523896-821691F9-DA69-434E-A329-199AF4964B74Q47103806-79FA2B2F-300D-46CD-BE1E-8F939D09C6D4Q54210009-E2393B23-9D3F-4688-A48A-452E49AB495CQ57930420-9105E2E9-4E13-43F5-9FD8-2255C57D0825
P2860
Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Increased weight loss with red ...... d with murine cytomegalovirus.
@en
Increased weight loss with red ...... d with murine cytomegalovirus.
@nl
type
label
Increased weight loss with red ...... d with murine cytomegalovirus.
@en
Increased weight loss with red ...... d with murine cytomegalovirus.
@nl
prefLabel
Increased weight loss with red ...... d with murine cytomegalovirus.
@en
Increased weight loss with red ...... d with murine cytomegalovirus.
@nl
P2093
P2860
P1476
Increased weight loss with red ...... d with murine cytomegalovirus.
@en
P2093
M H Qureshi
O R Oakley
S Humphreys
P2860
P304
P356
10.1111/J.1365-2249.2007.03533.X
P577
2007-11-14T00:00:00Z